# Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy

> clinical trial · VERIFIED · 2026-08-05

Status: ENROLLING_BY_INVITATION · Sponsor: AbbVie · Condition: Diabetic Retinopathy, DR

- Company: AbbVie
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT05296447

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.